Cargando…

Invasive Mold Infections (IMI) among Liver Transplant Recipients (LTR): Is It Time to Reconsider the Risk Factors that Determine Antifungal Prophylaxis?

BACKGROUND: IMI have high mortality among LTR. Prevention is critical. Data supporting guideline-recommended three-tiered approach to antifungal prophylaxis based on risk for IMI are lacking. METHODS: Retrospective study of 534 adult LTR at the Cleveland Clinic (CCF) August 2010–December 2014. We an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neyra, Karyna, Brizendine, Kyle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632168/ http://dx.doi.org/10.1093/ofid/ofx163.017

Ejemplares similares

Economic impact of an increased incidence of invasive mold infections (IMI)
por: Van Delden, C, et al.
Publicado: (2011)

Inhaled Antifungal Agents for Treatment and Prophylaxis of Bronchopulmonary Invasive Mold Infections
por: Brunet, Kévin, et al.
Publicado: (2022)

Mold-Active Antifungal Prophylaxis in Pediatric Patients with Cancer or Undergoing Hematopoietic Cell Transplantation
por: Lehrnbecher, Thomas, et al.
Publicado: (2023)

Invasive Mold Infections in Solid Organ Transplant Recipients
por: Crabol, Yoann, et al.
Publicado: (2014)

89. Efficacy and Tolerability of Voriconazole (VOR) vs. Isavuconazole (ISA) Prophylaxis (px) in Preventing Invasive Fungal Infections (IFI) in Lung Transplant Recipients (LTR)
por: Samanta, Palash, et al.
Publicado: (2019)

1086. Epidemiology, Risk Factors, and Effect of Antifungal Prophylaxis on Early Invasive Fungal Infection in Heart Transplant Recipients
por: Yetmar, Zachary A, et al.
Publicado: (2020)

2739. Evaluation of a Perioperative Fungal Prophylaxis Protocol Change in Orthotopic Liver Transplant
por: Shulkosky, Megan, et al.
Publicado: (2023)

Invasive Mold Infections (IMIs) of the Central Nervous System (CNS) in Patients with Hematologic Cancer (HC) (2000–2016): Uncommon but Deadly
por: Economides, Minas Platon, et al.
Publicado: (2017)

Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta‐analysis
por: Gatti, Milo, et al.
Publicado: (2021)

Invasive Non-Aspergillus Mold Infections in Transplant Recipients, United States, 2001–2006
por: Park, Benjamin J., et al.
Publicado: (2011)

Invasive Aspergillosis among Lung Transplant Recipients during Time Periods with Universal and Targeted Antifungal Prophylaxis—A Nationwide Cohort Study
por: Crone, Cornelia Geisler, et al.
Publicado: (2023)

Incidence of Invasive Fungal Infections in Liver Transplant Recipients under Targeted Echinocandin Prophylaxis
por: Breitkopf, Robert, et al.
Publicado: (2023)

1291. Safety of Isavuconazole Compared with Voriconazole as Primary Antifungal Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients
por: Bogler, Yael, et al.
Publicado: (2020)

1996. Invasive Fungal Infections in Orthotopic Heart Transplant: Incidence and Risk Factors in the Modern Era
por: Hasan, Lana, et al.
Publicado: (2023)

1136. Universal Prophylaxis for Prevention of Invasive Aspergillus in Lung Transplant Recipients
por: Guenette, Alexis, et al.
Publicado: (2018)

82. Incidence rates of invasive aspergillosis among lung transplant recipients in timeperiods with universal and targeted antifungal prophylaxis - a nationwide cohort study
por: Crone, Cornelia G, et al.
Publicado: (2022)

Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients
por: Lehrnbecher, Thomas, et al.
Publicado: (2020)

Posaconazole oral suspension for secondary antifungal prophylaxis in allogeneic stem cell transplantation recipients: a retrospective study
por: Ye, Peipei, et al.
Publicado: (2022)

Outpatient Antimicrobial Stewardship Intervention Targeting Cytomegalovirus (CMV) Viremia in Solid Organ Transplant (SOT) Recipients
por: Wang, Nan, et al.
Publicado: (2017)

Real-Life Considerations on Antifungal Treatment Combinations for the Management of Invasive Mold Infections after Allogeneic Cell Transplantation
por: Glampedakis, Emmanouil, et al.
Publicado: (2021)

416. Culture-Documented Invasive Mold Infections (cIMIs) at MD Anderson Cancer Center (MDACC) in Houston, Texas Pre- and Post-Hurricane Harvey
por: Kontoyiannis, Dimitrios P, et al.
Publicado: (2018)

Invasive Fungal Breakthrough Infections under Targeted Echinocandin Prophylaxis in High-Risk Liver Transplant Recipients
por: Breitkopf, Robert, et al.
Publicado: (2023)

635. Is Azole Prophylaxis in Liver Transplant Recipients Effective in Preventing Invasive Candidiasis in the Era of Emerging Resistance?
por: Gurram, Pooja R, et al.
Publicado: (2022)

Micafungin as antifungal prophylaxis in non-transplanted haemotological patients
por: Villaescusa, Teresa, et al.
Publicado: (2020)

Antifungal Prophylaxis
por: Johnson, Douglas Clark, et al.
Publicado: (2021)

Epidemiology and Risk Factors for Invasive Fungal Infections in Pancreas Transplant in the Absence of Postoperative Antifungal Prophylaxis
por: Zachary, Jessica, et al.
Publicado: (2023)

Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress?
por: Roth, Romain Samuel, et al.
Publicado: (2021)

LB21. Preemptive Therapy (PET) vs. Prophylaxis for Prevention of Cytomegalovirus (CMV) Disease in High-Risk Donor Seropositive/Recipient Seronegative (D+R−) Liver Transplant Recipients (LTR): A NIH-Sponsored, Randomized, Controlled, Multicenter Trial
por: Singh, Nina, et al.
Publicado: (2018)

IMI Impact of Myopia
por: Sankaridurg, Padmaja, et al.
Publicado: (2021)

IMI Pathologic Myopia
por: Ohno-Matsui, Kyoko, et al.
Publicado: (2021)

IMI 2023 Digest
por: Sankaridurg, Padmaja, et al.
Publicado: (2023)

Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study
por: Rinaldi, Matteo, et al.
Publicado: (2021)

Antifungal prophylaxis with nebulized amphotericin-B in solid-organ transplant recipients with severe COVID-19: a retrospective observational study
por: Rombauts, Alexander, et al.
Publicado: (2023)

Pneumocystis jirovecii pneumonia in liver transplant recipients in an era of routine prophylaxis
por: Andreasen, Philip B., et al.
Publicado: (2021)

Antifungal Therapy in Hematopoietic Stem Cell Transplant Recipients
por: Busca, Alessandro, et al.
Publicado: (2016)

Indication of Liver Transplantation for Hepatocellular Carcinoma Should Be Reconsidered in Case of Microvascular Invasion and Multilocular Tumor Occurrence
por: Gundlach, Jan-Paul, et al.
Publicado: (2021)

755. Predictors of Mortality in Invasive Mold Infections Among Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant Recipients
por: Gupta, Aanchal, et al.
Publicado: (2022)

P354 Mold infections in solid organ transplant recipients in indian setting
por: Enaganthi, Niveditha, et al.
Publicado: (2022)

1129. Targeted Voriconazole Prophylaxis in Heart Transplantation Recipients
por: Lin, Michael, et al.
Publicado: (2018)

Infections in Lung Transplant Recipients during and after Prophylaxis
por: Bae, Moonsuk, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hpauv2lj0gcq6odgn1dc1qmapm